Yablonka Uri (CIK 1608814) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-29). Recent activity: Buy BCLI (150,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | EVP & Chief Business Officer | Buy | 150,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-29